MedPath

OPD-based trial for Treatment adherence, tolerability and safety of Ayurveda therapeutic regimen in the management of Primary Knee Osteoarthritis

Phase 3
Conditions
Health Condition 1: M170- Bilateral primary osteoarthritis of knee
Registration Number
CTRI/2023/07/054948
Lead Sponsor
Central Council for Research in Ayurvedic Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Pain in knee + Any three of the following

1. Age > 50 years

2. less than 30 minutes of stiffness

3. crepitus

4. bony tenderness

5. bony enlargement

6. no palpable warmth

Exclusion Criteria

1. Grade 3 and above radiographic changes in the affected knee (Kellgren-Lawrence classification) 2. Significant trauma to the knee including arthroscopy within preceding one year

3. History of knee joint replacement

4. BMI more than equal to 30 kg per m²

5 History of prior intra-articular corticosteroid or hyaluronic acidadministration within one month of the study

6. Patient taking corticosteroids

7. Patient with history of Rheumatoid arthritis Psoriatic arthritis Psoriatic arthritis or any other type of inflammatory arthritis

8. history of hepatic disorders (more than three times upper normal limit of normal of liver enzymes) or renal disorders (serum creatinine more than 1.2 mg%)

9. History or active malignancy

10. Hypersensitivity to study interventions

11. Any other disease condition that in the opinion of the investigator may compromise the participants safety or compliance

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary <br/ ><br>1. Assessment of treatment adherence through self-reported compliance log and used medication containers/strips <br/ ><br>2. Assessment of the tolerability of the Ayurveda therapeutic regimen through reported incidence of adverse events (GIT-related AE specifically) during the study period <br/ ><br>3. Change in the laboratory safety parameters from baseline (CBC, LFT, KFT)Timepoint: 1. (Time frame: day 30, 60, 90, 120, 150, 180) <br/ ><br>2. (Time frame: day 30, 60, 90, 120, 150, 180) <br/ ><br>3. (Time frame: baseline, day 90, 180)
Secondary Outcome Measures
NameTimeMethod
1. Change in WOMAC index score for pain, stiffness and physical function from baseline <br/ ><br>2. Change in the score of Numeric Pain rating scale from baseline <br/ ><br>3. Change in health related quality of life from baseline assessed through SF-12 questionnaire <br/ ><br>4. Change in the need of Rescue Analgesic medication <br/ ><br>Timepoint: 1. Time frame: day 30, 60, 90, 120, 150, 180 <br/ ><br>2. Time frame: day 30, 60, 90, 120, 150, 180 <br/ ><br>3. Time frame: day 30, 60, 90, 120, 150, 180 <br/ ><br>4. Time frame: day 30, 60, 90, 120, 150, 180
© Copyright 2025. All Rights Reserved by MedPath